These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1545470)

  • 21. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 22. Challenges for development of meningococcal vaccines in infants and children.
    Deasy A; Read RC
    Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal disease in Ontario during the winter of 1988-1989.
    Heimann GA; Mikel DE; Naus M; Goel V; Tischler M; Carlson JA; Schabas R; Pasut G; Borczyk A; Krishnan C
    Can Dis Wkly Rep; 1989 Mar; 15(11):59-62. PubMed ID: 2713946
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment and prevention of meningococcal disease.
    Greenwood BM
    Trop Doct; 1984 Apr; 14(2):61-6. PubMed ID: 6428011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010].
    Posmyk U; Hryniewicz W; Skoczyńska A; Kumala R
    Pol Merkur Lekarski; 2012 May; 32(191):287-92. PubMed ID: 22779333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].
    Renevey F; Demierre G; Chuard C; Regamey C
    Rev Med Suisse Romande; 2001 Aug; 121(8):569-72. PubMed ID: 11565217
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for control of meningococcal disease. The Advisory Committee on Epidemiology.
    Can Dis Wkly Rep; 1991 Nov; 17(45):245-50. PubMed ID: 1843653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebrospinal meningitis and anti-meningococcal vaccination].
    Triau R
    Prog Immunobiol Stand; 1971; 5():454-71. PubMed ID: 4581659
    [No Abstract]   [Full Text] [Related]  

  • 32. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 33. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis.
    Pérez-Trallero E; Vicente D; Montes M; Cisterna R
    Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines for control of meningococcal disease. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Ottawa, Ontario, Canada.
    Can Commun Dis Rep; 1994 Feb; 20(3):17-27. PubMed ID: 8167604
    [No Abstract]   [Full Text] [Related]  

  • 35. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand.
    Arnold R; Galloway Y; McNicholas A; O'Hallahan J
    Vaccine; 2011 Sep; 29(40):7100-6. PubMed ID: 21803101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations].
    Gendrel D
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The outbreaks of invasive meningococcal disease in the municipalities of Goleniów and Przybiernów in March 2009. Control measures taken in the outbreak area].
    Gatalska M; Marcinkowska BE; Opiela R; Sygit M
    Przegl Epidemiol; 2011; 65(3):429-32. PubMed ID: 22184943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.